Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 505
interventional 410
Observational 91
Registry 4

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 254
Drug|Procedure 43
Device 23
Drug|Other 23
Procedure 22
Drug|placebo 13
Device|Drug 7
Behavioral 3
Biological 3
Biological|Drug 3
Other 3
Biological|Procedure 2
Combination Product 2
Dietary Supplement|placebo 2
Behavioral|Drug|Procedure 1
Biological|Other 1
Biological|Radiation 1
Combination Product|Device 1
Device|Other 1
Drug|Other|placebo 1
Other|placebo 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 159
NA 37
China 15
Canada 14
Brazil 13
Korea, Republic of 13
France 9
Austria 8
Japan 8
Australia 7
Mexico 7
United Kingdom 7
Egypt 6
Germany 6
Iran, Islamic Republic of 6
India 5
Denmark 4
Norway 3
United States|Canada 3
Israel 2
Italy 2
Malaysia 2
Spain 2
Syrian Arab Republic 2
Taiwan 2
Turkey 2
Argentina|Mexico 1
Australia|Austria|Czech Republic|Denmark|France|Germany|Hungary|Italy|Japan|Poland|Spain|Taiwan 1
Australia|Belgium|Canada|Czech Republic|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Latvia|Netherlands|Russian Federation|Singapore|Slovakia|Spain|Switzerland|Turkey|United Kingdom 1
Australia|Belgium|Canada|France|Germany|Greece|Hungary|Italy|Netherlands|Spain|Switzerland|Turkey|United Kingdom 1
Australia|Canada|Denmark|France|Germany|Italy|Spain|United Kingdom 1
Australia|Denmark|Germany|Italy|Netherlands 1
Austria|Australia|Canada|Czech Republic|Denmark|Greece|Hungary|Ireland|Italy|Netherlands|Poland|Portugal|Slovakia|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
Austria|Belgium|Germany|Hungary|Netherlands|Portugal|Spain 1
Austria|Canada|Czechia|France|Germany|Hungary|Italy|Lithuania|Poland|Portugal|Slovakia|Spain|Switzerland|United Kingdom 1
Belgium 1
Belgium|Czech Republic|France|Greece|Hungary|Ireland|Italy|Netherlands|Poland|Portugal|Spain|Switzerland|United Kingdom 1
Belgium|France|Germany|Greece|Hungary|Portugal|Spain|United Kingdom 1
Belgium|France|Germany|Slovakia|Spain|Switzerland|United Kingdom 1
Belgium|Germany|Italy|Netherlands|Spain|United Kingdom 1
Bulgaria|Belgium|Czechia|Denmark|Estonia|France|Germany|Hungary|India|Korea, Republic of|Latvia|Lebanon|Lithuania|Malaysia|Norway|Poland|Russian Federation|Singapore|Slovakia|Sweden|Switzerland|Taiwan|Turkey 1
Bulgaria|Czech Republic|Denmark|Germany|Hungary|Italy|Netherlands|Poland|Spain|United Kingdom 1
Chile 1
China|Hong Kong|Indonesia|Philippines|Taiwan|Vietnam 1
China|Hong Kong|Japan|Korea, Republic of|Singapore|Taiwan 1
China|Hong Kong|Korea, Republic of|Russian Federation 1
China|India 1
China|Philippines 1
Croatia 1
Cuba 1
Czech Republic|Germany|Hungary|Poland|United Kingdom 1
Czechia|Hungary|Slovakia 1
Finland|Spain|Sweden|United Kingdom 1
France|Germany|Israel|Italy|Spain|United Kingdom 1
Germany|Austria|Canada|Czechia|France|Hungary|Italy|Lithuania|Poland|Portugal|Slovakia|Spain|Switzerland|United Kingdom 1
Germany|Hungary|Poland|United Kingdom 1
Hungary|United States|Austria|Bulgaria|France|Germany|Israel|Italy|Japan|Mexico|Peru|Poland|Russian Federation|Slovakia|Spain|Turkey 1
Indonesia 1
Israel|United States|Australia|Latvia 1
Italy|United States|Argentina|Australia|Austria|Canada|Colombia|Israel|Japan|Netherlands|Portugal|Puerto Rico|Spain|United Kingdom 1
Japan|Korea, Republic of 1
Kuwait 1
Lebanon 1
Portugal 1
Portugal|Spain 1
Singapore 1
Slovakia|United States|Hungary|Israel|Puerto Rico 1
Switzerland 1
Switzerland|United States|Argentina|Australia|Brazil|Canada|China|Czechia|Denmark|France|Germany|Hong Kong|Hungary|Italy|Korea, Republic of|Poland|Portugal|Russian Federation|Singapore|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Australia 1
United States|Australia|Austria|Brazil|Canada|Colombia|Czechia|Denmark|France|Germany|Greece|India|Italy|Netherlands|Portugal|South Africa|Switzerland|United Kingdom 1
United States|Australia|Austria|Canada|Czechia|France|Germany|Israel|Mexico|Philippines|Portugal|South Africa|Taiwan 1
United States|Australia|Belgium|Czech Republic|France|Germany|Israel|Italy|Poland|Spain 1
United States|Australia|Brazil|Canada|Denmark|France|Germany|India|Italy|Mexico|Netherlands|Poland|Portugal|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Australia|Canada|Czech Republic|Germany|Israel|Philippines|Portugal|South Africa|Spain 1
United States|Australia|Canada|India|United Kingdom 1
United States|Australia|Canada|Israel|South Africa 1
United States|Australia|Canada|United Kingdom 1
United States|Austria|Canada 1
United States|Austria|Canada|China|Denmark|France|Germany|Hong Kong|Israel|Italy|Japan|Puerto Rico|Russian Federation|Slovakia|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Belgium|Czech Republic|Germany|Israel|Poland|United Kingdom 1
United States|Belgium|Denmark|France|Germany|Israel|Italy|Netherlands|Portugal|South Africa|Spain|United Kingdom 1
United States|Brazil|Canada|Colombia|France|Hungary|India|Italy|Korea, Republic of|New Zealand|Poland|Singapore|Taiwan|United Kingdom 1
United States|Brazil|Canada|Colombia|Hong Kong|India|Italy|Korea, Republic of|New Zealand|Poland|Singapore|Spain|United Kingdom 1
United States|Canada|Colombia|India|Israel 1
United States|Canada|Denmark|Germany|Lithuania|Mexico|Portugal|Romania|Spain|United Kingdom 1
United States|Czechia|Germany|Hungary|India|Japan|Latvia|Poland|Russian Federation 1
United States|Germany|Puerto Rico|Spain 1
United States|India|Israel 1
United States|Korea, Republic of 1
United States|Puerto Rico 1
United States|United Kingdom 1

Sites per Study

Site_count Study_Count
1 232
2 33
3 12
4 14
5 6
6 9
7 7
8 1
9 1
10 2
11 2
12 4
13 8
14 3
15 2
16 3
17 2
18 5
20 6
21 2
25 1
26 1
28 1
29 1
32 1
33 2
34 1
35 4
37 1
39 2
41 2
42 2
43 2
47 1
50 2
51 3
56 2
61 2
64 3
65 1
66 1
68 1
73 1
76 3
78 1
80 1
84 2
85 1
90 2
95 1
99 1
100 1
103 1
106 1
123 1
187 1
196 1

Phase

Phase Study_Count
Phase 4 86
Phase 3 85
Phase 2 83
N/A 70
Phase 1 36
Phase 1/Phase 2 33
Phase 2/Phase 3 16
Early Phase 1 1

Number of Arms

Number_of_Arms Count_of_Studies
1 101
2 172
3 73
4 20
5 5
6 2
7 2
8 4
9 1
NA 30

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 16 5.0000 3.00000 5.00000 0.0000 10.00000 5.0000 6.00000
1st Qu. 16 28.5000 5.00000 17.00000 33.7500 31.25000 87.0000 30.00000
Median 16 55.0000 15.00000 29.00000 61.0000 48.00000 262.0000 50.00000
Mean 16 180.5714 30.05714 40.54839 102.8875 73.35714 323.9176 87.31765
3rd Qu. 16 115.0000 43.00000 47.00000 125.2500 68.50000 463.0000 82.00000
Max. 16 4500.0000 121.00000 153.00000 1004.0000 317.00000 1260.0000 560.00000

Trial Group Type

group_type Group_Count
Experimental 444
Active Comparator 279
Sham Comparator 39
Placebo Comparator 36
NA 30
Other 29
No Intervention 9

Intervention Model

intervention_model Study_Count
Parallel Assignment 249
Single Group Assignment 129
NA 14
Crossover Assignment 10
Sequential Assignment 6
Factorial Assignment 2

Primary Purpose

primary_purpose Study_Count
Treatment 354
Prevention 23
Other 10
Basic Science 6
Diagnostic 6
NA 6
Health Services Research 2
Supportive Care 2
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 24
NA 9
France 8
Germany 7
Portugal 5
Austria 4
Canada 4
Switzerland 4
Mexico 3
United Kingdom 3
Belgium 2
Japan 2
Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Colombia|Costa Rica|Czech Republic|Dominican Republic|Ecuador|Egypt|France|Germany|Greece|Guatemala|Hong Kong|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|Panama|Peru|Poland|Portugal|Russian Federation|Saudi Arabia|Singapore|Slovakia|Slovenia|Spain|Turkey|Ukraine|United Kingdom|Venezuela 1
Argentina|Colombia|Costa Rica|Mexico 1
Australia 1
Austria|Switzerland 1
Brazil 1
China 1
China|Egypt|France|Germany|Italy|Kuwait|Lebanon|Russian Federation|Saudi Arabia|Taiwan|United Arab Emirates 1
Denmark|Norway|Sweden 1
Egypt 1
Finland|France|Israel|Italy|Portugal|Spain|Sweden|United Kingdom 1
France|Germany|Greece|Portugal|Russian Federation|Slovakia|Spain|United Kingdom 1
France|Germany|Spain|United Kingdom 1
Pakistan 1
Poland 1
Turkey 1
United Arab Emirates 1

Sites per Study

Site_count Study_Count
1 68
2 4
3 4
4 5
6 1
8 1
11 1
18 1
23 1
25 2
32 1
48 1
463 1

Enrollment Metrics

Measure Observational
Min 1.0000
1st Qu 40.0000
Median 87.0000
Mean 781.4111
3rd Qu 313.0000
Max 30490.0000

Observation Model

observational_model Study_Count
Cohort 54
Case-Only 19
Case-Control 6
Other 6
Case Control 2
Ecologic or Community 2
NA 2

Time Perspective

time_perspective Study_Count
Prospective 66
Retrospective 16
Cross-Sectional 5
Other 2
NA 2

Registries

Studies by Country

Country Study_Count
France 1
Germany 1
Mexico 1
United States 1

Sites per Study

Site_count Study_Count
1 3
3 1

Enrollment Metrics

Measure Registries
Min 60.00
1st Qu 90.00
Median 329.50
Mean 429.75
3rd Qu 669.25
Max 1000.00

Registry Model

observational_model Study_Count
Cohort 2
Case-Only 1
Case Control 1

Time Perspective

time_perspective Study_Count
Prospective 4

Follow-up

target_duration Study_Count
5 Years 2
1 Day 1
12 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03405376 Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT03405376 Recruiting Yeungnam University College of Medicine 2019-03-31
NCT03396861 Treatment of Macular Edema After Cataract Surgery With Subconjunctival Aflibercept https://ClinicalTrials.gov/show/NCT03396861 Recruiting Tufts Medical Center 2020-05-31
NCT03383328 Study for Optimizing Anti-inflammatory Prophylaxis https://ClinicalTrials.gov/show/NCT03383328 Completed Rigshospitalet, Denmark 2019-12-18
NCT03859245 Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer’s Disease Prevention https://ClinicalTrials.gov/show/NCT03859245 Recruiting Bristlecone Health, Inc. 2020-09-30
NCT03340610 IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab https://ClinicalTrials.gov/show/NCT03340610 Completed Southeast Retina Center, Georgia 2018-12-31
NCT03328715 iOCT for Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03328715 Recruiting Vienna Institute for Research in Ocular Surgery 2020-09-01
NCT03321513 DRCR.Net Aflibercept vs. Bevacizumab + Deferred Aflibercept for the Treatment of CI-DME https://ClinicalTrials.gov/show/NCT03321513 Active, not recruiting Jaeb Center for Health Research 2021-12-20
NCT03292796 RCT to Investigate if Prostaglandin Analogue Drops Increase the Risk of Cystoid Macular Oedema After Cataract Surgery. https://ClinicalTrials.gov/show/NCT03292796 Active, not recruiting Norfolk and Norwich University Hospitals NHS Foundation Trust 2019-12-31
NCT03270865 Usability and Ergonomic Evaluation of Self-Positioning System for Retinal Imaging https://ClinicalTrials.gov/show/NCT03270865 Completed Notal Vision Ltd 2018-02-01
NCT03261635 Ranibizumab Plus Indomethacin https://ClinicalTrials.gov/show/NCT03261635 Completed Università degli Studi di Brescia 2016-12-07
NCT03246152 Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA https://ClinicalTrials.gov/show/NCT03246152 Completed Cairo University 2018-12-24
NCT03226951 SDM Laser for Non Central Diabetic CSME https://ClinicalTrials.gov/show/NCT03226951 Completed Marashi Eye Clinic 2018-01-31
NCT03223714 Conbercept Ophthalmic Injection for Patients of Central Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT03223714 Recruiting Chengdu Kanghong Biotech Co., Ltd. 2019-12-31
NCT03211741 Longterm Efficiency and Safety of Intravitreal Injections With Bevacizumab in Patients With Neovascularisation or Macular Edema https://ClinicalTrials.gov/show/NCT03211741 Recruiting University Hospital, Ghent 2021-01-01
NCT03197480 Diabetic Macular Edema Asian Response (DEAR) Study: Biomarkers for Response to Aflibercept in Asian Patients With Center Involving DME https://ClinicalTrials.gov/show/NCT03197480 Recruiting Singapore National Eye Centre 2020-12-31
NCT03161652 Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03161652 Recruiting Universidad Nacional Autonoma de Mexico 2022-05-31
NCT03143192 Treatment of Diabetic Macular Edema With Aflibercept and Micropulse Laser https://ClinicalTrials.gov/show/NCT03143192 Completed Toronto Retina Institute 2019-05-09
NCT03126786 Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03126786 Completed Clearside Biomedical, Inc. 2018-04-17
NCT03108352 Conbercept Ophthalmic Injection for Patients With Macular Edema Caused by Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT03108352 Recruiting Chengdu Kanghong Biotech Co., Ltd. 2019-12-31
NCT03094819 PROTECT2: Diabetes Care - Eye Exam https://ClinicalTrials.gov/show/NCT03094819 Active, not recruiting Retinal Care Inc. 2021-06-30
NCT03093701 TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT03093701 Active, not recruiting Taiwan Liposome Company 2020-12-31
NCT03071068 A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME) https://ClinicalTrials.gov/show/NCT03071068 Completed ThromboGenics 2018-04-30
NCT03056092 Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab https://ClinicalTrials.gov/show/NCT03056092 Recruiting St. Michael’s Hospital, Toronto 2020-02-28
NCT03056079 Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept https://ClinicalTrials.gov/show/NCT03056079 Recruiting St. Michael’s Hospital, Toronto 2020-02-28
NCT03038048 30g vs 33g Needle for Intravitreal Injections https://ClinicalTrials.gov/show/NCT03038048 Completed Wills Eye 2017-04-27
NCT03025945 Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo https://ClinicalTrials.gov/show/NCT03025945 Completed Intuor Technologies, Inc. 2017-01-31
NCT02985619 Bevacizumabe or Triamcinolone for Persistent Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02985619 Completed University of Sao Paulo 2017-04-14
NCT02953938 Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety https://ClinicalTrials.gov/show/NCT02953938 Completed Novartis 2018-12-28
NCT02951351 Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections https://ClinicalTrials.gov/show/NCT02951351 Completed Mayo Clinic 2018-02-01
NCT02949024 Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02949024 Completed Clearside Biomedical, Inc. 2017-04-12
NCT02914613 Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT02914613 Completed SciFluor Life Sciences, Inc. 2017-05-16
NCT02867735 A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Intravitreal LKA651 in Patients With Macular Edema https://ClinicalTrials.gov/show/NCT02867735 Completed Novartis 2018-02-15
NCT02834663 Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02834663 Completed Wonkwang University Hospital 2019-02-28
NCT02826655 Adaptive Optics for Ophthalmic Technologies https://ClinicalTrials.gov/show/NCT02826655 Recruiting Duke University 2021-06-30
NCT02818998 Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT02818998 Completed Bayer 2018-11-13
NCT02796183 The Efficacy of Subconjunctival Bevacizumab in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02796183 Completed Neon Hospital 2016-04-30
NCT02790775 Pain and Visual Outcome in Intravitreal Bevacizumab Injection https://ClinicalTrials.gov/show/NCT02790775 Completed Shahid Beheshti University of Medical Sciences 2016-05-30
NCT02788877 Treat-and-extend Regimen of Aflibercept in Diabetic Macular Edema (VIBIM Study) https://ClinicalTrials.gov/show/NCT02788877 Active, not recruiting Pusan National University Hospital 2019-09-30
NCT02772497 3 Month Outcome of Ziv-aflibercept for DME https://ClinicalTrials.gov/show/NCT02772497 Completed Marashi Eye Clinic 2016-05-31
NCT02764697 Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients https://ClinicalTrials.gov/show/NCT02764697 Completed Tampa Bay Uveitis Center, LLC 2016-12-07
NCT02734407 Long-Term Efficacy and Safety of Aflibercept Intravitreal Injections for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02734407 Completed Retina-Vitreous Associates Medical Group 2017-09-27
NCT02732951 Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02732951 Completed Boehringer Ingelheim 2017-10-23
NCT02712008 Anti-vasculaR Endothelial Growth Factor plUs Anti-angiopoietin 2 in Fixed comBination therapY: Evaluation for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02712008 Completed Regeneron Pharmaceuticals 2017-07-10
NCT02699450 A Study of Faricimab (RO6867461) in Participants With Center-involving Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02699450 Completed Hoffmann-La Roche 2017-09-15
NCT02698566 A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS) https://ClinicalTrials.gov/show/NCT02698566 Completed Genentech, Inc. 2016-04-05
NCT02688309 Pro-permeability and Pro-fibrosis Factors in the Aqueous of Patients With Retinal Diseases https://ClinicalTrials.gov/show/NCT02688309 Recruiting Johns Hopkins University 2021-07-31
NCT02663141 Randomized Clinical Trial of Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Combined With Losartan in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02663141 Completed Tehran University of Medical Sciences 2016-06-30
NCT02646670 Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02646670 Completed Instituto de Olhos de Goiania 2015-10-31
NCT02646072 Effect of Preoperative Topical Ketorolac on Aqueous Cytokine Levels and Macular Thickness in Cataract Surgery Patients https://ClinicalTrials.gov/show/NCT02646072 Completed University of Malaya 2015-05-31
NCT02645266 Mean Visual Acuity Changes Following Five Injections of Aflibercept https://ClinicalTrials.gov/show/NCT02645266 Recruiting McMaster University 2018-12-31
NCT02634333 Anti-VEGF Treatment for Prevention of PDR/DME https://ClinicalTrials.gov/show/NCT02634333 Active, not recruiting Jaeb Center for Health Research 2020-05-31
NCT02633852 Multicenter Study to Evaluate the Efficacy of Treat and Extend Regimen of Aflibercept (EYLEA) as a Second Line Treatment for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02633852 Completed Hadassah Medical Organization 2018-08-28
NCT02623426 Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial https://ClinicalTrials.gov/show/NCT02623426 Active, not recruiting JHSPH Center for Clinical Trials 2021-01-31
NCT02614937 Study of Squalamine Lactate for the Treatment of Macular Edema Related to Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT02614937 Completed Ohr Pharmaceutical Inc. 2014-12-31
NCT02609165 Nerve Growth Factor Eye Drops Treatment in Patients With Retinitis Pigmentosa and Cystoid Macular Edema https://ClinicalTrials.gov/show/NCT02609165 Completed Ospedale San Raffaele 2017-02-28
NCT02595398 Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis https://ClinicalTrials.gov/show/NCT02595398 Completed Clearside Biomedical, Inc. 2018-01-18
NCT02800642 Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO https://ClinicalTrials.gov/show/NCT02800642 Completed Bayer 2019-07-31
NCT02571972 Dorzolamide-timolol Drops With Injections to Treat AMD, RVO or DME. https://ClinicalTrials.gov/show/NCT02571972 Completed Wills Eye 2015-09-30
NCT02559180 Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab https://ClinicalTrials.gov/show/NCT02559180 Recruiting The Cleveland Clinic 2020-11-30
NCT02556723 Intravitreal Injections of Ziv-aflibercept for Macular Diseases https://ClinicalTrials.gov/show/NCT02556723 Completed Retina Clinic, Sao Paulo, Brazil 2015-09-30
NCT03397264 A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03397264 Active, not recruiting Opthea Limited 2020-05-31
NCT02556424 Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema https://ClinicalTrials.gov/show/NCT02556424 Recruiting Nantes University Hospital 2020-10-31
NCT02554747 Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa https://ClinicalTrials.gov/show/NCT02554747 Completed Odense University Hospital 2017-12-31
NCT02530918 Study of DS-7080a for the Treatment of Macular Degeneration https://ClinicalTrials.gov/show/NCT02530918 Completed Daiichi Sankyo, Inc. 2018-01-02
NCT02510885 SD-OCT Angiography https://ClinicalTrials.gov/show/NCT02510885 Recruiting Duke University 2020-05-31
NCT02503540 Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO https://ClinicalTrials.gov/show/NCT02503540 Completed The Cleveland Clinic 2018-02-06
NCT02486484 Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection https://ClinicalTrials.gov/show/NCT02486484 Recruiting Rafic Hariri University Hospital 2019-05-31
NCT02478515 Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT02478515 Completed Nagoya City University 2019-03-31
NCT02472366 A Non-Randomized, Open-Label, Single Center Phase 4 Study of the Effect and Safety of ILUVIEN® in Chronic Diabetic Macular Edema Patients Considered Insufficiently Responsive to Available Therapies (Laser, Anti-VEGF) With or Without Intravitreal Corticosteroid Therapy https://ClinicalTrials.gov/show/NCT02472366 Completed Alimera Sciences 2015-03-31
NCT02471651 Dexamethasone Intravitreal Implant for the Treatment of Persistent Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02471651 Completed California Retina Consultants 2018-10-24
NCT02457975 Photobiomodulation for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02457975 Completed Medical College of Wisconsin 2019-08-30
NCT02457884 Effectiveness of Training in Reading Rehabilitation for Patients With Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT02457884 Completed The Hong Kong Polytechnic University 2018-03-31
NCT02448446 The Effect of Intravitreal Ranibizumab on Visual Acuity and Hard Exudate Resolution in the Treatment of Diabetic Macular Edema With Center Involved Edema and Lipid Exudates https://ClinicalTrials.gov/show/NCT02448446 Completed South Coast Retina Center; Carson, McBeath, Boswell, Inc. 2018-05-31
NCT02443012 Topical Nepafenac as Supplement for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02443012 Completed Universiti Sains Malaysia 2014-08-31
NCT02441907 Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02441907 Completed St. Michael’s Hospital, Toronto 2018-08-31
NCT02424019 Phase 4 IOP Signals Associated With ILUVIEN® https://ClinicalTrials.gov/show/NCT02424019 Active, not recruiting Alimera Sciences 2019-12-31
NCT02406157 577nm Micropulse Laser Versus 532nm Subthreshold Laser Photocoagulation for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02406157 Completed Sun Yat-sen University 2018-07-31
NCT02403128 Intravitreal Aflibercept Injection for Symptomatic Macular Edema From Retinal Artery Macroaneurysms https://ClinicalTrials.gov/show/NCT02403128 Active, not recruiting Illinois Retina and Eye Associates 2020-02-29
NCT02392364 Variable Interval Versus Set Interval Aflibercept for DME https://ClinicalTrials.gov/show/NCT02392364 Completed California Retina Consultants 2018-11-15
NCT02363621 Evaluation of Inflammation and Pain Post Injection of Ranibizumab vs Aflibercept in Patients With DME https://ClinicalTrials.gov/show/NCT02363621 Completed Sierra Eye Associates 2017-10-31
NCT02359526 A Pilot Study on the Effect and Safety of Iluvien® in Chronic Diabetic Macular Edema Patients https://ClinicalTrials.gov/show/NCT02359526 Completed Association for Innovation and Biomedical Research on Light and Image 2016-03-31
NCT02348918 Phase 2 Randomized Clinical Trial of Luminate® as Compared to Avastin® in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02348918 Completed Allegro Ophthalmics, LLC 2017-05-16
NCT02314299 A Study of MTP-131 Topical Ophthalmic Solution in Subjects With Diabetic Macular Edema and Non-Exudative Intermediate Age-related Macular Degeneration https://ClinicalTrials.gov/show/NCT02314299 Completed Stealth BioTherapeutics Inc. 2015-05-31
NCT02310295 Prospective, Randomized Clinical Trial Comparing Macular Photocoagulation With or Without Intravitreal Bevacizumab or Triamcinolone for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02310295 Completed University of Sao Paulo 2011-12-31
NCT02308644 Intravitreous Bevacizumab and Standard Metabolic Control for Diabetic Macular Edema - A Contrast Sensitivity Study https://ClinicalTrials.gov/show/NCT02308644 Completed University of Sao Paulo 2011-12-31
NCT02303184 Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO https://ClinicalTrials.gov/show/NCT02303184 Completed Clearside Biomedical, Inc. 2016-03-31
NCT02302079 A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT02302079 Completed Astellas Pharma Inc 2016-08-12
NCT02299336 Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial https://ClinicalTrials.gov/show/NCT02299336 Completed Greater Houston Retina Research 2017-01-09
NCT02297204 The Endurance 1 Trial https://ClinicalTrials.gov/show/NCT02297204 Completed Northern California Retina Vitreous Associates 2017-12-13
NCT02294656 Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide https://ClinicalTrials.gov/show/NCT02294656 Completed Soll Eye 2018-09-30
NCT02262260 Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME https://ClinicalTrials.gov/show/NCT02262260 Completed Novartis 2017-09-12
NCT02259088 A 12-month, Randomized, Efficacy and Safety Study of 0.5 mg Ranibizumab vs Laser in Chinese Diabetic Macular Edema (DME) Patients https://ClinicalTrials.gov/show/NCT02259088 Completed Novartis 2017-01-17
NCT02255032 Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis https://ClinicalTrials.gov/show/NCT02255032 Completed Clearside Biomedical, Inc. 2015-12-31
NCT02245516 Exploratory Study of KPI-121 Effect on Intra- or Subretinal Fluid Due to Retinal Vein Occlusion/Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02245516 Completed Kala Pharmaceuticals, Inc. 2014-12-31
NCT02221453 Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide https://ClinicalTrials.gov/show/NCT02221453 Completed St. Michael’s Hospital, Toronto 2016-12-31
NCT02207712 Noctura400 Treatment for Diabetic Retinopathy (CANDLE) https://ClinicalTrials.gov/show/NCT02207712 Active, not recruiting PolyPhotonix Medical 2020-07-31
NCT02193113 A Phase I Single Ascending Dose Study of the Intravitreal Plasma Kallikrein Inhibitor KVD001 in Subjects With DME https://ClinicalTrials.gov/show/NCT02193113 Completed KalVista Pharmaceuticals, Ltd. 2015-06-04
NCT02186119 A Study of Abicipar Pegol in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02186119 Completed Allergan 2015-06-30
NCT02181400 Near Infrared Photobiomodulation Treatment for Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT02181400 Completed University of Sydney 2019-02-15
NCT02140411 Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. https://ClinicalTrials.gov/show/NCT02140411 Completed Novartis 2016-12-21
NCT02140164 Study of Oral Minocycline in Treating Bilateral Cystoid Macular Edema Associated With Retinitis Pigmentosa https://ClinicalTrials.gov/show/NCT02140164 Completed National Institutes of Health Clinical Center (CC) 2015-11-30
NCT02121262 A Safety and Efficacy Study of Dexamethasone Versus Laser Photocoagulation in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02121262 Completed Allergan 2019-10-09
NCT02118831 Systemic Pharmacokinetics Following Intravitreal Injections of Anti-VEGF https://ClinicalTrials.gov/show/NCT02118831 Completed California Retina Consultants 2014-02-28
NCT02107131 Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab https://ClinicalTrials.gov/show/NCT02107131 Completed California Retina Consultants 2017-05-15
NCT02103283 A Phase 1, Open-Label Study of Teprotumumab in Patients With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT02103283 Completed River Vision Development Corporation 2016-08-31
NCT02084576 Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification https://ClinicalTrials.gov/show/NCT02084576 Completed Hospital Oftalmologico de Brasilia 2013-08-31
NCT01315275 A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema https://ClinicalTrials.gov/show/NCT01315275 Completed Novartis 2012-08-31
NCT01309451 Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01309451 Completed Maturi, Raj K., M.D., P.C. 2013-04-30
NCT01304706 Fluocinolone Acetonide in Diabetic Macular Edema (FAME) Extension Study https://ClinicalTrials.gov/show/NCT01304706 Completed Alimera Sciences 2013-11-30
NCT01298076 Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT01298076 Completed University of Sydney 2014-09-30
NCT01297569 Ranibizumab “Treat and Extend” in Diabetic Macular Edma https://ClinicalTrials.gov/show/NCT01297569 Completed Novartis 2012-11-30
NCT01292798 Ranibizumab 0.5mg and 2.0mg to Treat Diabetic Macular Edema in Patients With Poor Response to Bevacizumab https://ClinicalTrials.gov/show/NCT01292798 Completed California Retina Consultants 2013-04-30
NCT01284478 Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery https://ClinicalTrials.gov/show/NCT01284478 Completed Northern California Retina Vitreous Associates 2012-10-31
NCT01277302 A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01277302 Completed Genentech, Inc. 2012-10-31
NCT01273727 Ozurdex for Macular Edema Post Membrane Peeling https://ClinicalTrials.gov/show/NCT01273727 Completed Retina Specialists, PC 2014-04-30
NCT02050828 The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02050828 Completed Aerpio Therapeutics 2015-04-30
NCT02036424 Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Alone Versus Ozurdex Given Every 3 Months for Treatment of Persistent Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02036424 Completed Maturi, Raj K., M.D., P.C. 2015-08-31
NCT03355638 Treatment of CNV With Aflibercept Combined With Pranoprofen Eye Drops or Nutraceutical Support With Omega-3 https://ClinicalTrials.gov/show/NCT03355638 Completed Università degli Studi di Brescia 2016-07-31
NCT02006147 Phase 1 Open-label Study to Evaluate Efficacy and Tolerability of TLC399 in Patients With Macular Edema Due to RVO https://ClinicalTrials.gov/show/NCT02006147 Active, not recruiting Taiwan Liposome Company 2020-12-31
NCT02002403 Efficacy and Safety Study to Evaluate Two Doses of Oral DMI-5207 in Adult Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02002403 Completed St. Michael’s Hospital, Toronto 2012-04-30
NCT01997164 Study of Intravitreal (IVT) REGN910-3 and IVT REGN910 in Patients With Either Neovascular (“Wet”) Age Related Macular Degeneration (AMD) or Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01997164 Completed Regeneron Pharmaceuticals 2015-10-31
NCT01988246 Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery https://ClinicalTrials.gov/show/NCT01988246 Completed The Cleveland Clinic 2018-04-25
NCT01982435 Safety and Efficacy of Ranibizumab for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01982435 Completed The Cleveland Clinic 2016-05-26
NCT01976338 Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) https://ClinicalTrials.gov/show/NCT01976338 Completed Novartis 2016-03-28
NCT01975103 Non-damaging Retinal Laser Therapy With PASCAL Laser for Macular Diseases https://ClinicalTrials.gov/show/NCT01975103 Recruiting Federal University of Rio Grande do Sul 2020-04-30
NCT04418427 ADVM-022 Intravitreal Gene Therapy for DME https://ClinicalTrials.gov/show/NCT04418427 Recruiting Adverum Biotechnologies, Inc. 2021-05-31
NCT01939691 Macular Edema Nepafenac vs. Difluprednate Uveitis Trial https://ClinicalTrials.gov/show/NCT01939691 Recruiting University of California, San Francisco 2020-11-30
NCT01934556 A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01934556 Completed Palmetto Retina Center, LLC 2017-04-30
NCT01909791 Treatment for CI-DME in Eyes With Very Good VA Study https://ClinicalTrials.gov/show/NCT01909791 Completed Jaeb Center for Health Research 2018-09-11
NCT01903720 A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01903720 Completed Allergan 2014-09-24
NCT01908816 An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. https://ClinicalTrials.gov/show/NCT01908816 Completed Novartis 2016-01-08
NCT01892163 Multicentre Randomised Clinical Trial Comparing Fixed vs Pro re Nata (PRN) Dosing of 700 μg Dexamethasone https://ClinicalTrials.gov/show/NCT01892163 Completed Moorfields Eye Hospital NHS Foundation Trust 2014-12-31
NCT01875783 OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits https://ClinicalTrials.gov/show/NCT01875783 Completed Joslin Diabetes Center 2015-05-14
NCT01870440 TAHOE: Intravitreal Dexamethasone Implant (Ozurdex) for Uveitic Macular Edema https://ClinicalTrials.gov/show/NCT01870440 Completed Northern California Retina Vitreous Associates 2015-02-28
NCT01870427 NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions https://ClinicalTrials.gov/show/NCT01870427 Completed Northern California Retina Vitreous Associates 2015-08-31
NCT01846299 To Assess the Efficacy and Safety of Intravitreal Ranibizumab in People With Vision Loss Due to Macular Edema https://ClinicalTrials.gov/show/NCT01846299 Completed Novartis 2015-09-30
NCT01823965 Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment https://ClinicalTrials.gov/show/NCT01823965 Completed Poitiers University Hospital 2014-07-31
NCT01823081 Combined Intravitreal Fasudil and Bevacizumab for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01823081 Completed Shahid Beheshti University of Medical Sciences 2013-06-30
NCT01821677 AP-05-002 A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug)in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01821677 Completed Ampio Pharmaceuticals. Inc. 2014-06-30
NCT01787669 Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT01787669 Completed University of Sydney 2017-01-31
NCT01783886 Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement https://ClinicalTrials.gov/show/NCT01783886 Completed Bayer 2015-03-31
NCT01774474 PRevention of Macular EDema After Cataract Surgery https://ClinicalTrials.gov/show/NCT01774474 Completed Maastricht University Medical Center 2016-11-04
NCT01767545 Dexamethasone-implant for the Treatment of RVO https://ClinicalTrials.gov/show/NCT01767545 Completed Ludwig-Maximilians - University of Munich 2011-01-31
NCT01766362 Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients. https://ClinicalTrials.gov/show/NCT01766362 Completed Centre Hospitalier Universitaire Dijon 2015-11-30
NCT01748487 The Effect of Intravitreal Ozurdex on DME After Cataract Surgery https://ClinicalTrials.gov/show/NCT01748487 Completed University Health Network, Toronto 2015-09-30
NCT01732614 Topcon Endpoint Management https://ClinicalTrials.gov/show/NCT01732614 Completed Retinal Consultants of Arizona 2013-11-30
NCT01702441 Safety and Pilot Efficacy of AKB-9778 in Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01702441 Completed Aerpio Therapeutics 2013-09-30
NCT01698788 Effect of Intraoperative Dexamethasone Implant in Taut Posterior Hyaloid Removal in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01698788 Completed Postgraduate Institute of Medical Education and Research 2011-12-31
NCT01698749 Effect of Intravitreal Long Acting Dexamethasone Implant, Ozurdex in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01698749 Completed Postgraduate Institute of Medical Education and Research 2012-01-31
NCT01694212 Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01694212 Completed Eye Clinic Medic Zuljan Jukic 2016-10-31
NCT01673191 A 3-Month Clinical Trial to Assess the Safety and Efficacy of the OZURDEX® Intraocular Implant in Patients With Diabetes Mellitus https://ClinicalTrials.gov/show/NCT01673191 Completed Retinal Consultants of Arizona 2014-12-31
NCT01662518 DDS-25 Gauge in Patients With Macular Edema Secondary to Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT01662518 Completed Centro de Pesquisa Rubens Siqueira 2016-01-31
NCT01661946 Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye https://ClinicalTrials.gov/show/NCT01661946 Completed Queen’s University 2013-07-31
NCT01660802 Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT01660802 Completed Allergan 2014-03-31
NCT01640171 Anesthesia Preference for Intravitreal Injection: Topical or Subconjunctival https://ClinicalTrials.gov/show/NCT01640171 Completed Retina Vitreous Associates of Florida 2013-09-30
NCT01638858 Treatment of Diabetic Macular Edema With 0.5mg Intraocular Ranibizumab (Lucentis) https://ClinicalTrials.gov/show/NCT01638858 Completed University of Luebeck 2014-07-31
NCT01627249 Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01627249 Completed Jaeb Center for Health Research 2014-10-31
NCT01613716 Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study) https://ClinicalTrials.gov/show/NCT01613716 Completed The Cleveland Clinic 2016-12-31
NCT01610557 Ranibizumab and Bevacizumab for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01610557 Completed National Institutes of Health Clinical Center (CC) 2015-02-28
NCT01579760 Intravitreal Aflibercept Injection for Radiation Retinopathy https://ClinicalTrials.gov/show/NCT01579760 Completed Washington University School of Medicine 2019-01-31
NCT01571232 Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01571232 Completed Retina Macula Institute 2014-02-28
NCT01564108 The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema https://ClinicalTrials.gov/show/NCT01564108 Completed Moorfields Eye Hospital NHS Foundation Trust 2014-06-30
NCT01552408 Efficacy & Safety Trial of Intravitreal Injections Combined With PRP for CSME Secondary to Diabetes Mellitus (DAVE) https://ClinicalTrials.gov/show/NCT01552408 Completed Greater Houston Retina Research 2017-05-18
NCT01546402 Intraoperative Dexamethasone Implant Improves Outcome of Cataract Surgery With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01546402 Completed Postgraduate Institute of Medical Education and Research 2012-11-30
NCT01542190 Comparison of Topical Ketorolac 0,4% Versus Placebo in Cataract Surgery https://ClinicalTrials.gov/show/NCT01542190 Completed University of Campinas, Brazil 2012-12-31
NCT01535261 Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01535261 Completed Novartis 2015-03-31
NCT01512901 Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI) https://ClinicalTrials.gov/show/NCT01512901 Completed Santen Pharmaceutical Co., Ltd. NA
NCT01506895 A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01506895 Completed GlaxoSmithKline 2013-02-28
NCT01492400 Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01492400 Completed Allergan 2014-02-13
NCT01476449 Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema https://ClinicalTrials.gov/show/NCT01476449 Completed Retina Vitreous Associates of Florida 2016-09-30
NCT01473251 Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration https://ClinicalTrials.gov/show/NCT01473251 Completed Vitreo-Retinal Associates, Michigan 2014-04-30
NCT01472510 Ranibizumab in Residual Diabetic Macular Edema Following Previous Anti-VEGF Therapy https://ClinicalTrials.gov/show/NCT01472510 Completed Vitreo-Retinal Associates, PC 2013-07-31
NCT01471691 Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab https://ClinicalTrials.gov/show/NCT01471691 Completed Hanscom, Thomas, M.D. 2014-02-28
NCT01449682 Efficacy of an Intravitreal DEX Implant in Retinal Vein Occlusion Following Treatment With Anti-VEGF Injections. https://ClinicalTrials.gov/show/NCT01449682 Completed Retina Macula Institute 2012-07-31
NCT01445899 PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01445899 Completed Quark Pharmaceuticals 2013-11-30
NCT01442064 An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2) https://ClinicalTrials.gov/show/NCT01442064 Completed Genentech, Inc. 2010-07-31
NCT01441102 Dextromethorphan for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01441102 Completed National Institutes of Health Clinical Center (CC) 2014-06-30
NCT01428388 Bevacizumab Versus Ranibizumab in Treatment of Macular Edema From Vein Occlusion https://ClinicalTrials.gov/show/NCT01428388 Completed Barnes Retina Institute 2015-10-31
NCT01427751 Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01427751 Completed Allergan 2014-11-04
NCT01411254 Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA) https://ClinicalTrials.gov/show/NCT01411254 Completed Santen Pharmaceutical Co., Ltd. NA
NCT01396083 Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Central Retinal Vein Occlusion (CRVO) https://ClinicalTrials.gov/show/NCT01396083 Completed Novartis 2014-01-31
NCT01396057 Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO) https://ClinicalTrials.gov/show/NCT01396057 Completed Novartis 2013-06-30
NCT01395069 Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery https://ClinicalTrials.gov/show/NCT01395069 Completed Queen’s University 2011-05-31
NCT01385852 CME With Different Fluidic Parameters https://ClinicalTrials.gov/show/NCT01385852 Completed Iladevi Cataract and IOL Research Center 2011-02-28
NCT01376362 Topical Interferon Gamma for Macular Edema Secondary to Uveitis https://ClinicalTrials.gov/show/NCT01376362 Completed National Institutes of Health Clinical Center (CC) 2012-02-29
NCT01363440 Study of Intravitreal Aflibercept Injection (IAI; EYLEA®; BAY86-5321) in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01363440 Completed Regeneron Pharmaceuticals 2013-01-31
NCT01355692 Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01355692 Completed Lumenis Ltd. 2015-06-30
NCT01342159 Intravitreal Bevacizumab and Triamcinolone in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01342159 Completed Hallym University Medical Center 2010-02-28
NCT01331681 Intravitreal Aflibercept Injection in Vision Impairment Due to DME https://ClinicalTrials.gov/show/NCT01331681 Completed Bayer 2013-06-30
NCT01331005 NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01331005 Completed Jaeb Center for Health Research 2013-12-31
NCT01324869 Safety and Efficacy by Multiple Injection of KH902 in Patients With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01324869 Completed Chengdu Kanghong Biotech Co., Ltd. 2012-02-29
NCT01319487 Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01319487 Completed Fovea Pharmaceuticals SA 2012-03-31
NCT04411693 Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04411693 Recruiting The Cleveland Clinic 2021-06-01
NCT04359771 Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04359771 Completed Cairo University 2018-09-25
NCT04332133 Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04332133 Completed Minia University 2019-03-31
NCT04290195 Use of Ziv Aflibercept in Different Retinal Diseases https://ClinicalTrials.gov/show/NCT04290195 Completed Tanta University 2019-12-01
NCT04288232 Efficacy and Safety of Aflibercept as Mono-therapy in Treat and Extend Regimen for DME Patients in Taiwan https://ClinicalTrials.gov/show/NCT04288232 Completed Taipei Veterans General Hospital, Taiwan 2017-11-16
NCT04234438 Management of Cystoid Macular Edema Secondary to Retinitis Pigmentosa Via Subliminal Micropulse Yellow Laser https://ClinicalTrials.gov/show/NCT04234438 Completed Ankara Universitesi Teknokent 2019-10-30
NCT04187443 MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema https://ClinicalTrials.gov/show/NCT04187443 Recruiting MingSight Pharmaceuticals Pty Limited 2021-08-18
NCT04186702 New Concepts in Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT04186702 Completed Ain Shams University 2016-10-01
NCT04151407 The Study of Drug 601 in Patients With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT04151407 Recruiting Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 2020-12-31
NCT04142164 Computer-based Tutorial and Automated Speech Recognition for Intravitreal Drug Injections https://ClinicalTrials.gov/show/NCT04142164 Recruiting Vienna Institute for Research in Ocular Surgery 2021-01-01
NCT04129021 Multimodal Ophthalmic Imaging https://ClinicalTrials.gov/show/NCT04129021 Recruiting Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts 2023-06-30
NCT04120636 Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole https://ClinicalTrials.gov/show/NCT04120636 Recruiting Targeted Therapy Technologies, LLC 2020-10-30
NCT04120311 Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole https://ClinicalTrials.gov/show/NCT04120311 Recruiting Targeted Therapy Technologies, LLC 2020-08-25
NCT04119921 Short-term Additive Effect of Topical Ketorolac on the Management of Diabetic Macular Edema With Intravitreal Bevacizumab https://ClinicalTrials.gov/show/NCT04119921 Active, not recruiting Shahid Beheshti University of Medical Sciences 2018-06-01
NCT04108156 This Study Will Evaluate the Efficacy, Safety, and Pharmacokinetics of the Port Delivery System With Ranibizumab in Participants With Diabetic Macular Edema Compared With Intravitreal Ranibizumab https://ClinicalTrials.gov/show/NCT04108156 Recruiting Hoffmann-La Roche 2021-10-31
NCT04089605 Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04089605 Completed Far Eastern Memorial Hospital 2018-11-01
NCT04087746 Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT04087746 Completed Minia University 2019-01-31
NCT04085341 A Depot Formulation of Sunitinib Malate (GB-102) in Subjects With Diabetic Macular Edema and Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT04085341 Active, not recruiting Graybug Vision 2020-04-30
NCT04069780 Suprachoroidal Injection of Triamcinolone Acetonide for Management of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04069780 Recruiting Ain Shams University 2020-08-07
NCT04063358 Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery https://ClinicalTrials.gov/show/NCT04063358 Recruiting Second Military Medical University 2021-08-31
NCT04038125 Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME https://ClinicalTrials.gov/show/NCT04038125 Recruiting Retina Macula Specialists of Miami, LLC 2020-08-31
NCT04018482 Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study) https://ClinicalTrials.gov/show/NCT04018482 Completed California Retina Consultants 2019-08-14
NCT04014556 Aflibercept Plus Micropulse Laser Versus Aflibercept Monotherapy for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04014556 Completed University of Alexandria 2018-10-01
NCT04005430 A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema https://ClinicalTrials.gov/show/NCT04005430 Recruiting Targeted Therapy Technologies, LLC 2020-06-15
NCT03984110 The Use of a Combination of Ozurdex and Eylea Versus Eylea Monotherapy for Diabetic Macular Edema: A Prospective, Comparative Trial (COED Trial) https://ClinicalTrials.gov/show/NCT03984110 Recruiting Texas Retina Associates 2020-06-15
NCT03975088 Sub-macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03975088 Completed University of Alexandria 2017-12-31
NCT03974425 One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab https://ClinicalTrials.gov/show/NCT03974425 Completed University of Alexandria 2017-04-01
NCT03973138 Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab https://ClinicalTrials.gov/show/NCT03973138 Recruiting Sun Yat-sen University 2020-01-01
NCT03956797 Long Term Safety of Cooling Anesthesia for Intravitreal Injection https://ClinicalTrials.gov/show/NCT03956797 Recruiting Recens Medical, Inc. 2020-05-30
NCT03953807 A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated https://ClinicalTrials.gov/show/NCT03953807 Recruiting Allergan 2021-05-31
NCT03918590 Post Intravitreal Injection Topical NSAID vs. Patching https://ClinicalTrials.gov/show/NCT03918590 Enrolling by invitation The New York Eye & Ear Infirmary 2019-05-01
NCT03917472 Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03917472 Active, not recruiting Novartis 2021-07-30
NCT03908723 Treatment of Macular Edema Caused by Leber’s Miliary Aneurysms Using Intravitreal Aflibercept and Peripheral Laser Photocoagulation https://ClinicalTrials.gov/show/NCT03908723 Recruiting Alexandria University 2021-03-29
NCT03908307 Evaluation of OZURDEX® in Patients With Macular Edema Secondary to Retinal Vein Occlusion in China https://ClinicalTrials.gov/show/NCT03908307 Recruiting Allergan 2021-09-30
NCT03892434 Bevacizumab Versus DEX Implant Followed by Bevacizumab in ME Secondary to BRVO https://ClinicalTrials.gov/show/NCT03892434 Recruiting Yeungnam University College of Medicine 2019-12-18
NCT03866746 Aflibercept With and Without Micropulse Laser in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03866746 Completed Al Hadi Hospital 2017-06-21
NCT03866473 A Pilot Study Evaluating Photobiomodulation Therapy for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03866473 Active, not recruiting Jaeb Center for Health Research 2020-04-21
NCT03835884 A Study Assessing AR-13503 Implant Alone and in Combination With Aflibercept in Subjects With nAMD or DME https://ClinicalTrials.gov/show/NCT03835884 Active, not recruiting Aerie Pharmaceuticals 2021-09-30
NCT03832179 Steroid vs. Anti-vascular Endothelial Growth Factor for Diabetic Macular Edema Prior to Phacoemulsification https://ClinicalTrials.gov/show/NCT03832179 Recruiting Bay Area Retina Associates 2020-06-01
NCT03802630 Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT03802630 Recruiting Novartis 2023-05-26
NCT03759860 Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03759860 Active, not recruiting LUTRONIC Corporation 2019-07-30
NCT03739593 Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT03739593 Active, not recruiting Aerie Pharmaceuticals 2020-05-31
NCT03732287 Cooling Anesthesia for Intravitreal Injection https://ClinicalTrials.gov/show/NCT03732287 Completed Recens Medical, Inc. 2019-04-26
NCT03690947 Combination of Intravitreal Ranibizumab With or Without Micropulse Laser for the Treatment of DME https://ClinicalTrials.gov/show/NCT03690947 Recruiting Beijing Hospital 2020-09-30
NCT03690050 A Comparison of Standard Laser With Micropulse Laser for the Treatment of Diabetic Macular Oedema. https://ClinicalTrials.gov/show/NCT03690050 Recruiting Belfast Health and Social Care Trust 2020-12-31
NCT03666923 A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT03666923 Completed Oxurion 2019-11-20
NCT03660371 Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Vitreous Hemorrhaging https://ClinicalTrials.gov/show/NCT03660371 Recruiting Rush Eye Associates 2020-09-04
NCT03660345 Pars Plana Vitrectomy With Internal Limiting Membrane Peeling Versus Intravitreal Ziv-Aflibercept for Treatment-Naïve Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03660345 Recruiting Rush Eye Associates 2020-09-04
NCT03651011 Navigated Laser In Branch Retinal Vein Occlusion Study https://ClinicalTrials.gov/show/NCT03651011 Recruiting Odense University Hospital 2020-08-10
NCT03641144 Navigation Laser Versus Traditional Laser Photocoagulation for Mild Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03641144 Recruiting Sun Yat-sen University 2019-07-31
NCT03635814 The Study to YD312 Tablet in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03635814 Active, not recruiting YD Global Life Science Co., Ltd. 2018-07-27
NCT03622593 A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03622593 Enrolling by invitation Hoffmann-La Roche 2020-09-30
NCT03622580 A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) https://ClinicalTrials.gov/show/NCT03622580 Active, not recruiting Hoffmann-La Roche 2020-09-30
NCT03608839 Effect of Dexamethasone on Reduction of Macular Thickness in Diabetic Patients, a Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT03608839 Completed Universidade Federal de Pernambuco 2017-12-20
NCT03606733 Suprachoroidal Injection of Triamcinolone Acetonide Using Custom Made Needle to Treat Retinal Disorders https://ClinicalTrials.gov/show/NCT03606733 Recruiting Marashi Eye Clinic 2019-08-01
NCT03598205 Curcumin and Intravitreal Dexamethasone in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03598205 Completed Fondazione G.B. Bietti, IRCCS 2018-09-28
NCT03590444 Treatment of Diabetic Macular Edema (DME) With Anti-VEGF and Focal Laser https://ClinicalTrials.gov/show/NCT03590444 Completed Hospital Hietzing 2018-04-02
NCT03533478 Alzer® and Diamel® to Prevent Severe Diabetes Macular Edema https://ClinicalTrials.gov/show/NCT03533478 Completed Catalysis SL 2018-12-01
NCT03519581 Micropulse for Suppression of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03519581 Recruiting University of California, Davis 2020-12-31
NCT03511898 A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT03511898 Completed Oxurion 2019-05-22
NCT03499223 A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) https://ClinicalTrials.gov/show/NCT03499223 Completed Oxurion 2019-07-18
NCT03495765 To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus https://ClinicalTrials.gov/show/NCT03495765 Completed Marsden Eye Specialists 2017-01-01
NCT03481660 A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03481660 Active, not recruiting Novartis 2020-07-15
NCT03481634 Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03481634 Active, not recruiting Novartis 2020-11-11
NCT03466099 Study of the Intravitreal Plasma Kallikrein Inhibitor, KVD001, in Subjects With Center-involving Diabetic Macular Edema (ciDME) https://ClinicalTrials.gov/show/NCT03466099 Completed KalVista Pharmaceuticals, Ltd. 2019-10-10
NCT03465124 Evaluation of Central Macular Thickness in Femtosecond Laser-assisted Cataract Surgery https://ClinicalTrials.gov/show/NCT03465124 Active, not recruiting Medical University of Vienna 2019-02-19
NCT03453281 Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection https://ClinicalTrials.gov/show/NCT03453281 Completed Indonesia University 2018-04-09
NCT01259609 Changes in Ciliary Body Thickness in Patients With Diabetic Macular Edema After Vitrectomy https://ClinicalTrials.gov/show/NCT01259609 Completed Seoul National University Hospital 2010-04-30
NCT01257815 Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment https://ClinicalTrials.gov/show/NCT01257815 Completed Novartis 2013-04-30
NCT01247220 REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study https://ClinicalTrials.gov/show/NCT01247220 Completed Retina Associates of Florida, P.A. 2014-05-31
NCT01231633 Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO) https://ClinicalTrials.gov/show/NCT01231633 Completed Long Island Vitreoretinal Consultants 2014-09-30
NCT01219205 Major and Macular Branched Retinal Venous Occlusion https://ClinicalTrials.gov/show/NCT01219205 Completed Hallym University Medical Center 2009-02-28
NCT01208948 Clinical Trial on Alpha Lipoic Acid in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01208948 Completed Ludwig-Maximilians - University of Munich 2005-04-30
NCT01202461 Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01202461 Completed Samsung Medical Center 2010-08-31
NCT01198327 Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01198327 Completed Johns Hopkins University 2012-12-31
NCT01189461 Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01189461 Completed Pfizer 2012-07-31
NCT01175070 Intravitreal Macugen for Ischaemic Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT01175070 Completed University of Oxford 2013-03-31
NCT01171976 Efficacy and Safety of Ranibizumab in Two “Treat and Extend” Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus https://ClinicalTrials.gov/show/NCT01171976 Completed Novartis 2013-04-30
NCT01135914 Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01135914 Completed Novartis 2013-03-31
NCT01120899 A Pilot Study for the Evaluation of Minocycline as a Microglia Inhibitor in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01120899 Completed National Institutes of Health Clinical Center (CC) 2011-08-31
NCT01112085 MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2) https://ClinicalTrials.gov/show/NCT01112085 Completed Especialistas en Retina Medica y Quirurgica Grupo de Investigacion 2014-01-31
NCT01100307 A Phase 3 Study To Compare The Efficacy And Safety Of 0.3 MG Pegaptanib Sodium To Sham Injections In Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01100307 Completed Pfizer 2012-08-31
NCT01085734 Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01085734 Completed Maturi, Raj K., M.D., P.C. 2011-10-31
NCT01077401 Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study https://ClinicalTrials.gov/show/NCT01077401 Completed Johns Hopkins University 2012-03-31
NCT01030601 Analysis of the Effect of Intravitreal Dexamethasone Injection on Diabetic Macular Edema After Cataract Surgery (IDDMECS) https://ClinicalTrials.gov/show/NCT01030601 Completed University Health Network, Toronto 2011-01-31
NCT01028248 Lucentis for Macular Edema Associated With Central Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01028248 Completed California Retina Consultants 2012-06-30
NCT01027650 Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT01027650 Completed Allergan 2012-04-30
NCT00997191 Intravitreal Bevacizumab and Triamcinolone Associated to Laser Photocoagulation for Diabetic Macular Edema(IBeTA) https://ClinicalTrials.gov/show/NCT00997191 Completed University of Sao Paulo 2011-11-30
NCT00994955 Selective Retina Therapy (SRT) for Clinically Significant Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00994955 Completed University of Schleswig-Holstein 2008-12-31
NCT00989989 Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00989989 Completed Novartis 2011-08-31
NCT00974753 Prophylactic Ketorolac Post Epiretinal Membrane Surgery https://ClinicalTrials.gov/show/NCT00974753 Completed Queen’s University 2012-03-31
NCT00970957 Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT00970957 Completed Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 2013-02-28
NCT00970723 High Blood Pressure and Sleep Apnea in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00970723 Completed Assistance Publique - Hôpitaux de Paris 2014-01-31
NCT00943982 The Treatment of Uveitic Cystoid Macular Edema With Topical Interferon Gamma https://ClinicalTrials.gov/show/NCT00943982 Completed National Institutes of Health Clinical Center (CC) 2010-06-24
NCT00943072 Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) https://ClinicalTrials.gov/show/NCT00943072 Completed Regeneron Pharmaceuticals 2010-10-31
NCT00942864 Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT00942864 Completed Novartis 2009-12-31
NCT00915837 Safety and Tolerability Study of the Helical Intravitreal Triamcinolone Implant in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00915837 Completed SurModics, Inc. 2009-04-30
NCT00907114 Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00907114 Completed Hospital Juarez de Mexico 2015-03-31
NCT00901186 Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00901186 Completed Novartis 2012-08-31
NCT00900887 Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema https://ClinicalTrials.gov/show/NCT00900887 Completed Hospital Juarez de Mexico 2015-03-31
NCT00886808 Safety Study of iCo-007 Intravitreal Injection to Treat Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00886808 Completed iCo Therapeutics Inc. 2010-05-31
NCT00874744 Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00874744 Completed Universidade Federal de Goias 2008-09-30
NCT00846092 Near-infrared Light (NIR) Therapy for Diabetic Macular Edema: A Pilot Study https://ClinicalTrials.gov/show/NCT00846092 Completed Medical College of Wisconsin 2013-02-28
NCT04296838 Effects of Conbercept in Refractory Uveitic Macular Edema and VEGF https://ClinicalTrials.gov/show/NCT04296838 Recruiting Peking Union Medical College Hospital 2020-05-31
NCT03821168 The Effect of Intravitreal Erythropoietin Injection for Refractive Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03821168 Recruiting Shahid Beheshti University of Medical Sciences 2019-04-01
NCT00826618 Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema https://ClinicalTrials.gov/show/NCT00826618 Completed University of Miami 2012-09-30
NCT04448496 Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema https://ClinicalTrials.gov/show/NCT04448496 Recruiting Yeungnam University College of Medicine 2021-12-31
NCT03927690 Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03927690 Recruiting Novartis 2021-02-09
NCT01769352 Treatment of Post-surgical Cystoid Macular Edema With Topical Steroids Trial (TEMPEST-1) https://ClinicalTrials.gov/show/NCT01769352 Completed Johns Hopkins University 2016-04-30
NCT00815360 Ranibizumab and Peripheral Scatter Laser in Patients With Diabetic Macular Edema and Peripheral Nonperfusion https://ClinicalTrials.gov/show/NCT00815360 Completed Retina Associates of Florida, P.A. 2011-07-31
NCT01978015 Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAG https://ClinicalTrials.gov/show/NCT01978015 Completed University of Campinas, Brazil 2012-07-31
NCT01945866 Phase II Combination Steroid and Anti-VEGF for Persistent DME https://ClinicalTrials.gov/show/NCT01945866 Completed Jaeb Center for Health Research 2017-06-05
NCT01512966 Japanese Safety Study of VEGF Trap-Eye in DME (Diabetic Macular Edema) https://ClinicalTrials.gov/show/NCT01512966 Completed Bayer 2013-09-30
NCT01486238 Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study https://ClinicalTrials.gov/show/NCT01486238 Completed Valley Retina Institute 2011-07-31
NCT00806169 Combined Triple Therapy in Diabetic Retinopathy (DRP) https://ClinicalTrials.gov/show/NCT00806169 Completed Johann Wolfgang Goethe University Hospital 2008-10-31
NCT00804921 Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab https://ClinicalTrials.gov/show/NCT00804921 Completed University of Sao Paulo NA
NCT00801866 Avastin for Post-Photocoagulation Macular Edema https://ClinicalTrials.gov/show/NCT00801866 Completed Asociación para Evitar la Ceguera en México NA
NCT02581995 Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME. https://ClinicalTrials.gov/show/NCT02581995 Completed Bayer 2017-08-09
NCT03866005 Prospective Study of Adjunctive Carotenoids Plus Anti-oxidants in Anti-VEGF Treated Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03866005 Recruiting ZeaVision, LLC 2021-11-01
NCT03790852 Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO https://ClinicalTrials.gov/show/NCT03790852 Active, not recruiting Kodiak Sciences Inc 2021-06-30
NCT02374060 PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial https://ClinicalTrials.gov/show/NCT02374060 Completed JHSPH Center for Clinical Trials 2017-08-30
NCT01951066 Diabetic Macular Edema Treated With Ozurdex (DMEO) https://ClinicalTrials.gov/show/NCT01951066 Completed Johns Hopkins University 2015-12-31
NCT01573572 Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium https://ClinicalTrials.gov/show/NCT01573572 Completed Bausch Health Americas, Inc. 2019-11-04
NCT03610646 Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03610646 Recruiting Mylan Inc. 2020-02-28
NCT00790803 Pegaptanib Therapy in Non-Infectious Uveitic Cystoid Macular Edema https://ClinicalTrials.gov/show/NCT00790803 Completed Wake Forest University Health Sciences 2011-11-30
NCT00789477 DME And VEGF Trap-Eye [Intravitreal Aflibercept Injection (IAI;EYLEA®;BAY86-5321)] INvestigation of Clinical Impact https://ClinicalTrials.gov/show/NCT00789477 Completed Regeneron Pharmaceuticals 2009-12-31
NCT00782717 A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients https://ClinicalTrials.gov/show/NCT00782717 Completed Alcon Research 2010-07-31
NCT00780780 Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00780780 Completed Federal University of São Paulo 2008-08-31
NCT00764244 Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00764244 Completed Assistance Publique - Hôpitaux de Paris 2009-12-31
NCT00758628 Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema. https://ClinicalTrials.gov/show/NCT00758628 Completed Bp Consulting, Inc 2009-05-31
NCT00737971 Efficacy Study of Triamcinolone and Bevacizumab Intravitreal for Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00737971 Completed Federal University of São Paulo 2012-12-31
NCT00729846 Bevacizumab in Combination With Visudyne Photodynamic Therapy (PDT) https://ClinicalTrials.gov/show/NCT00729846 Completed California Retina Consultants 2008-08-31
NCT00711490 Sirolimus to Treat Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00711490 Completed National Institutes of Health Clinical Center (CC) 2011-01-31
NCT00687804 A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study https://ClinicalTrials.gov/show/NCT00687804 Completed Novartis 2010-01-31
NCT00687154 Observational Study of DME Following Scatter Laser Photocoagulation https://ClinicalTrials.gov/show/NCT00687154 Completed Jaeb Center for Health Research 2008-01-31
NCT00683176 Effect of Choline Fenofibrate (SLV348) on Macular Edema https://ClinicalTrials.gov/show/NCT00683176 Completed Abbott 2011-03-31
NCT00682539 Intraocular Anti-VEGF Compared With Intraocular Triamcinolone in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00682539 Completed Medical University of Vienna 2014-07-31
NCT00682240 Morphological and Functional Retinal Changes Following Retinal Photocoagulation https://ClinicalTrials.gov/show/NCT00682240 Completed Medical University of Vienna 2014-02-28
NCT00668239 Diffuse Diabetic Maculopathy With Intravitreal Triamcinolone or Laser https://ClinicalTrials.gov/show/NCT00668239 Completed Hospital de Clinicas de Porto Alegre 2006-04-30
NCT00665106 Safety and Tolerability of NOVA63035 “Corticosteroid” in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00665106 Completed Santen SAS 2011-09-30
NCT00656643 Dose Ranging Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00656643 Completed Santen Inc. 2009-11-30
NCT00612261 Sheathotomy vs. Intravitreal Triamcinolone for Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT00612261 Completed Yonsei University 2007-08-31
NCT00605280 A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension. https://ClinicalTrials.gov/show/NCT00605280 Completed Pfizer 2009-11-30
NCT00595543 Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5% https://ClinicalTrials.gov/show/NCT00595543 Completed Bp Consulting, Inc 2009-03-31
NCT00576459 Safety and Efficacy of Intravitreal Fluocinolone Acetonide Implants in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00576459 Completed Bausch & Lomb Incorporated 2006-06-30
NCT00571831 The Effect of a Blue Light Filtering IOL https://ClinicalTrials.gov/show/NCT00571831 Completed Showa University NA
NCT00567697 A Randomized Study Comparing Ranibizumab to Sham in Patients With Macular Edema Secondary to CRVO https://ClinicalTrials.gov/show/NCT00567697 Completed Aleris Helse 2008-10-31
NCT00536692 Topical Ocular Mecamylamine in Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT00536692 Completed CoMentis NA
NCT00508040 Evaluation of Birdshot Retine Choroidopathy Treatment by Either Steroid or Interferon alpha2a https://ClinicalTrials.gov/show/NCT00508040 Completed Assistance Publique - Hôpitaux de Paris 2011-10-31
NCT00502541 Efficacy of Fluocinolone Acetonide Intravitreal Implant in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00502541 Completed Bausch & Lomb Incorporated 2006-09-30
NCT00498355 Lucentis for Inflammatory Macular Edema Trial https://ClinicalTrials.gov/show/NCT00498355 Completed University of California, San Francisco 2009-01-31
NCT00496405 Unilateral Bevacizumab for Bilateral Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00496405 Completed Asociación para Evitar la Ceguera en México NA
NCT00494494 Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery https://ClinicalTrials.gov/show/NCT00494494 Completed University of North Carolina, Chapel Hill 2008-04-30
NCT00490815 Pharmacokinetic and Efficacy Study of Fluocinolone Acetonide Inserts in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00490815 Completed Alimera Sciences 2009-09-30
NCT00486018 A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion (BRAVO) https://ClinicalTrials.gov/show/NCT00486018 Completed Genentech, Inc. 2009-05-31
NCT00485836 A Study of the Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE) https://ClinicalTrials.gov/show/NCT00485836 Completed Genentech, Inc. 2009-06-30
NCT00476593 Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications https://ClinicalTrials.gov/show/NCT00476593 Completed Norwegian University of Science and Technology 2009-12-31
NCT00473382 A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RIDE) https://ClinicalTrials.gov/show/NCT00473382 Completed Genentech, Inc. 2011-01-31
NCT00473330 A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE) https://ClinicalTrials.gov/show/NCT00473330 Completed Genentech, Inc. 2010-11-30
NCT00469781 Bromfenac BID Plus Prednisolone Acetate BID Versus Bromfenac BID Plus Prednisolone QID for the Prevention of Cystoid Macular Edema and Retinal Thickening https://ClinicalTrials.gov/show/NCT00469781 Completed Center For Excellence In Eye Care 2008-09-30
NCT00464685 Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00464685 Completed Allergan 2010-02-08
NCT00446381 Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) https://ClinicalTrials.gov/show/NCT00446381 Completed Lawson Health Research Institute 2008-09-30
NCT00445003 Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00445003 Completed Jaeb Center for Health Research 2009-10-31
NCT00444600 Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00444600 Completed Jaeb Center for Health Research 2009-12-31
NCT00441662 Sub-Tenon Triamcinolone in the Prevention of Radiation-Induced Macular Edema https://ClinicalTrials.gov/show/NCT00441662 Completed Wills Eye NA
NCT00440609 Study Comparing 0.5mg of Ranibizumab and Higher Doses in the Treatment of Clinically Significant Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00440609 Completed Long Island Vitreoretinal Consultants 2012-11-30
NCT00412451 A Multicenter Study to Compare Multiple Doses of Intravitreal Microplasmin Versus Sham Injection for Treatment of Patients With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT00412451 Completed ThromboGenics 2010-01-31
NCT00411970 20- Versus 23- Gauge System for Pars Plana Vitrectomy https://ClinicalTrials.gov/show/NCT00411970 Completed The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery NA
NCT00407355 Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions https://ClinicalTrials.gov/show/NCT00407355 Completed Johns Hopkins University 2013-02-28
NCT00406107 Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT00406107 Completed Palmetto Retina Center, LLC 2007-12-31
NCT00403039 Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema https://ClinicalTrials.gov/show/NCT00403039 Completed Vitreous -Retina- Macula Consultants of New York 2011-12-31
NCT00401115 Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00401115 Completed Santen Inc. 2008-06-30
NCT00387582 Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00387582 Completed Rocky Mountain Retina Consultants 2009-02-28
NCT00379795 An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO https://ClinicalTrials.gov/show/NCT00379795 Completed Genentech, Inc. 2008-09-30
NCT00371410 Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00371410 Completed Samsung Medical Center NA
NCT00369863 A Randomized, Placebo-Controlled Clinical Trial of Intravitreal Triamcinolone for Refractory Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00369863 Completed Shahid Beheshti University of Medical Sciences NA
NCT00369486 A Pilot Study of Peribulbar Triamcinolone Acetonide for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00369486 Completed Jaeb Center for Health Research 2006-06-30
NCT00367133 Intravitreal Triamcinolone Acetonide Versus Laser for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00367133 Completed Jaeb Center for Health Research 2008-05-31
NCT00344968 Fluocinolone Acetonide Implant Compared to Sham Injection in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00344968 Completed Alimera Sciences 2009-12-31
NCT00344253 Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis https://ClinicalTrials.gov/show/NCT00344253 Completed Heidelberg University 2011-03-31
NCT00336323 A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) https://ClinicalTrials.gov/show/NCT00336323 Completed Jaeb Center for Health Research 2006-11-30
NCT00335439 Effect of Prophylactic Ketorolac on CME After Cataract Surgery https://ClinicalTrials.gov/show/NCT00335439 Completed Queen’s University 2007-05-31
NCT00333671 Quantification of Rising the Osmotic Pressure in Diabetic Intraretinal Fluid Accumulation (Diabetic Macular Oedema) https://ClinicalTrials.gov/show/NCT00333671 Completed Glostrup University Hospital, Copenhagen 2006-02-28
NCT00320814 Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00320814 Completed Regeneron Pharmaceuticals 2006-08-31
NCT00799227 Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00799227 Completed Allergan 2009-12-01
NCT00308542 A Study of the Safety and Efficacy of SK-0503 for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00308542 Completed Sanwa Kagaku Kenkyusho Co., Ltd. NA
NCT00308477 A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT00308477 Completed Sanwa Kagaku Kenkyusho Co., Ltd. NA
NCT00306904 Safety and Efficacy Study of Small Interfering RNA Molecule (Cand5) to Treat Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00306904 Completed OPKO Health, Inc. 2007-09-30
NCT00284050 Safety and Efficacy of Ranibizumab in Diabetic Macular Edema With Center Involvement https://ClinicalTrials.gov/show/NCT00284050 Completed Novartis 2008-06-30
NCT00280826 Efalizumab to Treat Uveitis https://ClinicalTrials.gov/show/NCT00280826 Completed National Institutes of Health Clinical Center (CC) 2009-02-28
NCT00231023 Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00231023 Completed National Institutes of Health Clinical Center (CC) NA
NCT00229931 Triamcinolone vs. Laser for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00229931 Completed University of Oklahoma 2013-05-31
NCT00168389 A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00168389 Completed Allergan 2012-06-30
NCT00168337 A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00168337 Completed Allergan 2012-05-31
NCT00168324 A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT00168324 Completed Allergan 2008-03-01
NCT00168298 A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT00168298 Completed Allergan 2008-03-01
NCT00167518 Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema That Persists After Laser Treatment (TDMO) https://ClinicalTrials.gov/show/NCT00167518 Completed University of Sydney NA
NCT00148330 Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study https://ClinicalTrials.gov/show/NCT00148330 Completed University of Sydney 2008-07-31
NCT00148265 A Multicentre Randomised Clinical Trial of Laser Treatment Plus Intravitreal Triamcinolone for Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT00148265 Completed University of Sydney 2009-05-31
NCT00133952 Effect of Ruboxistaurin on Clinically Significant Macular Edema https://ClinicalTrials.gov/show/NCT00133952 Completed Chromaderm, Inc. 2011-07-31
NCT00106132 Steroid Injections vs. Standard Treatment for Macular Edema Due to Retinal Blood Vessel Blockage https://ClinicalTrials.gov/show/NCT00106132 Completed National Institutes of Health Clinical Center (CC) NA
NCT00105404 Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation https://ClinicalTrials.gov/show/NCT00105404 Completed National Institutes of Health Clinical Center (CC) NA
NCT00105027 The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study https://ClinicalTrials.gov/show/NCT00105027 Completed The Emmes Company, LLC 2009-02-28
NCT00101764 Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders https://ClinicalTrials.gov/show/NCT00101764 Completed National Institutes of Health Clinical Center (CC) NA
NCT00090519 Reduction in the Occurrence of Center-Involved Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00090519 Completed Chromaderm, Inc. 2010-04-30
NCT00088283 Pegaptanib Sodium Compared to Sham Injection in Patients With Recent Vision Loss Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) https://ClinicalTrials.gov/show/NCT00088283 Completed Eyetech Pharmaceuticals NA
NCT00071773 A Pilot Study of Laser Photocoagulation for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00071773 Completed Jaeb Center for Health Research 2005-11-30
NCT00069056 Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00069056 Completed National Institutes of Health Clinical Center (CC) NA
NCT00050479 Laser and Medical Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00050479 Completed National Institutes of Health Clinical Center (CC) NA
NCT00040313 Pegaptanib Sodium Compared to Sham Injection in Patients With DME Involving the Center of the Macula https://ClinicalTrials.gov/show/NCT00040313 Completed Eyetech Pharmaceuticals NA
NCT00035906 Research Study in Patients With Persistent Macular Edema https://ClinicalTrials.gov/show/NCT00035906 Completed Allergan 2004-08-31
NCT00027287 Laser and Medical Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00027287 Completed National Institutes of Health Clinical Center (CC) NA
NCT00545870 Bevacizumab Versus Ranibizumab for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00545870 Completed Medical University of Vienna 2013-03-31
NCT00021645 Vitamin E to Treat Uveitis-Associated Macular Edema https://ClinicalTrials.gov/show/NCT00021645 Completed National Institutes of Health Clinical Center (CC) NA
NCT00407381 The Ranibizumab for Edema of the mAcula in Diabetes-2 (READ-2) Study https://ClinicalTrials.gov/show/NCT00407381 Completed Johns Hopkins University 2010-08-31
NCT00562406 Ranibizumab for Branch Retinal Vein Occlusion Associated Macular Edema Study (RABAMES) https://ClinicalTrials.gov/show/NCT00562406 Completed Klinikum Ludwigshafen 2010-09-30
NCT00055042 Laser and Antioxidant Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00055042 Completed National Institutes of Health Clinical Center (CC) NA
NCT00000115 Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema https://ClinicalTrials.gov/show/NCT00000115 Completed National Eye Institute (NEI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03470103 A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America https://ClinicalTrials.gov/show/NCT03470103 Active, not recruiting Bayer 2020-09-30
NCT03297684 Assessment of Biomarker Profile in Diabetic Macular Edema With Intravitreal Aflibercept Injection https://ClinicalTrials.gov/show/NCT03297684 Recruiting Advanced Eye Research Associates 2020-12-31
NCT02425501 Special Drug Use Investigation of EYLEA for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02425501 Completed Bayer 2019-04-26
NCT03157206 Diabetic Retinopathy Assessed by Ultra-wide https://ClinicalTrials.gov/show/NCT03157206 Recruiting Association Pour La Recherche En Vision Du Service D’Ophtalmologie De L’Hôpital 2019-07-18
NCT03112005 Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool https://ClinicalTrials.gov/show/NCT03112005 Completed Eyenuk, Inc. 2018-05-31
NCT03003416 Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT03003416 Completed Allergan 2018-12-19
NCT02979665 Changes to the Retina Following Anti-VEGF Treatments for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02979665 Completed Lawson Health Research Institute 2017-08-31
NCT02956330 Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201 https://ClinicalTrials.gov/show/NCT02956330 Completed Clearside Biomedical, Inc. 2017-04-12
NCT02933905 Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection https://ClinicalTrials.gov/show/NCT02933905 Completed Fundació Institut Germans Trias i Pujol 2015-01-31
NCT02924311 Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02924311 Completed Bayer 2019-08-12
NCT02876393 A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT02876393 Completed Queen’s University, Belfast 2017-01-31
NCT02874859 Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02874859 Recruiting Lille Catholic University 2019-12-31
NCT02731911 Study of OZURDEX® in the Treatment of Diabetic Macular Oedema (DME) in Australia - The AUSSIEDEX Study https://ClinicalTrials.gov/show/NCT02731911 Completed Allergan 2018-10-22
NCT02669953 Aflibercept in Recurrent or Persistent CNV https://ClinicalTrials.gov/show/NCT02669953 Recruiting Medical University of Vienna 2020-12-31
NCT02645747 Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT02645747 Completed Bayer 2017-12-23
NCT02639507 International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients https://ClinicalTrials.gov/show/NCT02639507 Completed Mayo Clinic 2020-03-31
NCT02623673 Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema https://ClinicalTrials.gov/show/NCT02623673 Completed Retina Clinic, Sao Paulo, Brazil 2015-12-31
NCT02637245 Imaging Parameters and DME Treatment Response https://ClinicalTrials.gov/show/NCT02637245 Recruiting Duke University 2020-05-31
NCT02585401 Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept in Canada https://ClinicalTrials.gov/show/NCT02585401 Completed Bayer 2016-03-31
NCT02887157 Analyzing Retinal Microanatomy in ROP https://ClinicalTrials.gov/show/NCT02887157 Recruiting Duke University 2021-03-31
NCT03404323 “Cataract Surgery in Eyes With Epiretinal Membrane” https://ClinicalTrials.gov/show/NCT03404323 Completed St John of God Hospital, Vienna 2016-07-01
NCT02555956 Grid Laser for Diffuse Diabetic Maculopathy https://ClinicalTrials.gov/show/NCT02555956 Completed Dow University of Health Sciences 2014-12-31
NCT03394573 Comparison of VA Guided Versus OCT Guided TER Using Aflibercept for Diabetic Macular Edema (AVOCT Study) https://ClinicalTrials.gov/show/NCT03394573 Recruiting University Hospital Inselspital, Berne 2021-09-30
NCT02540369 To Describe the Use of Intravitreal Aflibercept and to Describe Follow-up as Well as Treatment Patterns in Patients With Wet Age-related Macular Degeneration (wAMD) or Diabetic Macular Edema (DME) in Routine Clinical Practice in Canada. https://ClinicalTrials.gov/show/NCT02540369 Completed Bayer 2017-09-25
NCT02420132 Study to Evaluate Home Vision Testing in Participants Who Receive Ranibizumab (Lucentis®) https://ClinicalTrials.gov/show/NCT02420132 Completed Hoffmann-La Roche 2016-08-25
NCT02329132 Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02329132 Completed Kagawa University 2018-01-28
NCT02325271 Intra-individual Variability and Circadian Rhythm of VEGF Levels and Interaction With Biomarkers https://ClinicalTrials.gov/show/NCT02325271 Completed GWT-TUD GmbH 2015-10-31
NCT02232503 Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia https://ClinicalTrials.gov/show/NCT02232503 Completed Novartis 2015-11-30
NCT03385382 Ranibizumab Versus Dexamethasone Implant in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03385382 Completed G. d’Annunzio University 2017-06-27
NCT02217306 Contrast Sensitivity and Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02217306 Completed Hospital Juarez de Mexico 2014-07-31
NCT02194803 Observation of Treatment Patterns With Lucentis in Approved Indications https://ClinicalTrials.gov/show/NCT02194803 Completed Novartis 2016-12-31
NCT02188173 An Observational Study of OZURDEX® in Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT02188173 Completed Allergan 2016-05-31
NCT02181530 Retrospective Data Collection Study in Patients With Macular Oedema Receiving OZURDEX® https://ClinicalTrials.gov/show/NCT02181530 Completed Allergan 2014-10-31
NCT02121197 Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema. https://ClinicalTrials.gov/show/NCT02121197 Completed Association for Innovation and Biomedical Research on Light and Image 2016-01-31
NCT02088229 Relating Retinal Structural and Functional Parameters to Visual Acuity in Eyes Undergoing Treatment for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02088229 Completed University of Michigan 2015-06-30
NCT01314469 Quality of Life in Patients With Intermediate Uveitis https://ClinicalTrials.gov/show/NCT01314469 Completed St. Franziskus Hospital NA
NCT01299129 Functional and Morphologic Aspects of Intravitreal Triamcinolone for Uveitis-associated Cystoid Macular Edema https://ClinicalTrials.gov/show/NCT01299129 Completed Medical University of Vienna 2011-06-30
NCT01318941 Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting https://ClinicalTrials.gov/show/NCT01318941 Completed Novartis 2016-04-30
NCT02000102 Outcomes of Diabetic Macula Edema Patients Switched to Aflibercept From Bevacizumab and/or Ranibizumab https://ClinicalTrials.gov/show/NCT02000102 Completed Stanford University 2014-09-30
NCT01947881 Characterization of Eyes With Diabetic Macular Edema That Show Different Treatment Response to Intravitreal Anti-VEGF (CHARTRES) https://ClinicalTrials.gov/show/NCT01947881 Completed Association for Innovation and Biomedical Research on Light and Image 2015-02-28
NCT01934920 Identifying Patients With Unrecognized Treatable Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01934920 Recruiting Elman Retina Group 2019-05-31
NCT01918371 A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01918371 Completed Allergan 2014-09-04
NCT01876914 Pilot Study of OCT Versus Fluorescein Angiography in DME https://ClinicalTrials.gov/show/NCT01876914 Completed Oregon Health and Science University 2017-12-23
NCT01805323 A Retrospective Chart Review of OZURDEX® in Patients With Macular Edema https://ClinicalTrials.gov/show/NCT01805323 Completed Allergan 2013-04-15
NCT01792141 Use of Diagnostic Dye to Identify Areas of Leakeage,in the Retina, Prior to Receiving Focal Laser Treatment https://ClinicalTrials.gov/show/NCT01792141 Completed Retina Institute of Hawaii 2012-06-30
NCT01771081 Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy https://ClinicalTrials.gov/show/NCT01771081 Completed Bayer 2015-01-31
NCT01728883 Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study https://ClinicalTrials.gov/show/NCT01728883 Completed Vital Art and Science Incorporated 2016-04-30
NCT01692938 Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO https://ClinicalTrials.gov/show/NCT01692938 Completed Optos, PLC 2012-11-30
NCT01618266 Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01618266 Completed Allergan 2013-04-30
NCT01603823 Angiographie and OCT in Macula and Retinal Diseases https://ClinicalTrials.gov/show/NCT01603823 Completed Medical University of Vienna 2010-02-28
NCT01571557 A Safety and Efficacy Study to Assess OZURDEX® in Patients With Macular Oedema Secondary to Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT01571557 Completed Allergan 2014-03-31
NCT01568021 Post Market Surveillance of OZURDEX® for Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO) https://ClinicalTrials.gov/show/NCT01568021 Completed Allergan 2013-11-30
NCT01566526 Retrospective Data Collection Study in Patients Receiving Two or More OZURDEX® Injections for Macular Oedema Secondary to Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT01566526 Completed Allergan 2012-06-30
NCT01539577 A Long-Term Safety Study of OZURDEX® in Clinical Practice https://ClinicalTrials.gov/show/NCT01539577 Completed Allergan 2016-03-31
NCT01504074 Morphological and Functional Evaluation of Irvine-Gass Syndrome https://ClinicalTrials.gov/show/NCT01504074 Completed Medical University of Vienna 2014-07-31
NCT01485575 Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy https://ClinicalTrials.gov/show/NCT01485575 Recruiting University Hospital, Basel, Switzerland 2022-06-30
NCT01445626 A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT01445626 Completed Allergan 2012-01-31
NCT01411696 Retrospective Study in Patients Receiving Two or More OZURDEX® Injections for Retinal Vein Occlusion (RVO) https://ClinicalTrials.gov/show/NCT01411696 Completed Allergan 2012-03-31
NCT01358396 Glycemic Control and Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01358396 Completed Cairo University 2010-07-31
NCT04395859 Collateral Damage From the COVID-19 Pandemic Observed in Patients Treated With Intravitreal Injections (IVT) of Anti-angiogenic Agents https://ClinicalTrials.gov/show/NCT04395859 Recruiting Fondation Ophtalmologique Adolphe de Rothschild 2021-12-31
NCT04390126 COVID-19 Related Lockdown Effects On Chronic Diseases https://ClinicalTrials.gov/show/NCT04390126 Active, not recruiting Centre Hospitalier Universitaire Dijon 2021-05-07
NCT04387604 Effect of the Vitreous in Response to Intravitreal Injections of Ranibizumab for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04387604 Completed Centro Hospitalar do Porto 2018-02-01
NCT04161963 Incidence of Sub-clinical Cystoid Macular Edema After Cataract Surgery https://ClinicalTrials.gov/show/NCT04161963 Recruiting University of Zurich 2021-12-31
NCT04140448 Ultra-wide-field Fluorescein Angiography in Patients With Macular Edema Secondary to Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT04140448 Recruiting Renmin Hospital of Wuhan University 2021-10-30
NCT04018833 Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04018833 Completed Centro Hospitalar do Porto 2016-06-01
NCT03969303 NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients https://ClinicalTrials.gov/show/NCT03969303 Recruiting Notal Vision Ltd 2019-10-20
NCT03965078 Epiretinal Membrane and Cystoid Macular Oedema Post-cataract Surgery https://ClinicalTrials.gov/show/NCT03965078 Recruiting Portsmouth Hospitals NHS Trust 2020-11-30
NCT03927118 Effect of Dexamethasone Implant on Optic Disc https://ClinicalTrials.gov/show/NCT03927118 Completed Bulent Ecevit University 2018-09-01
NCT03889444 Chart Review: Drug Utilization Study in Participants Who Received Ozurdexâ„¢ (Dexamethasone Intravitreal Implant) 0.7 mg Injections for Visual Impairment Due to Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT03889444 Completed Allergan 2019-06-07
NCT03783832 Follow up of Diabetic Macular Edema Treated by Aflibercept (Eylea®) With OCT-Angiography https://ClinicalTrials.gov/show/NCT03783832 Recruiting Aquitania Opthalmologica 2019-12-31
NCT03753893 Ocular Manifestations in Rheumatic Diseases https://ClinicalTrials.gov/show/NCT03753893 Active, not recruiting Lawson Health Research Institute 2020-10-01
NCT03694145 Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images https://ClinicalTrials.gov/show/NCT03694145 Recruiting Charles Drew University of Medicine and Science 2020-09-30
NCT03665090 Shanghai Cohort Study of Diabetic Eye Disease https://ClinicalTrials.gov/show/NCT03665090 Enrolling by invitation Shanghai Eye Disease Prevention and Treatment Center 2018-12-31
NCT03597815 Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study https://ClinicalTrials.gov/show/NCT03597815 Active, not recruiting Uptown Eye Specialists 2018-12-31
NCT03590587 Rapid Structural and Functional Improvements in Following 0.19 mg Fluocinolone Acetonide (FAc) Implant in Diabetic Macular Edema Patients With Poor Visual Acuity: 12-month Audit Results From United Arab Emirates https://ClinicalTrials.gov/show/NCT03590587 Recruiting Benha University 2018-09-15
NCT03559491 Dexamethasone Intravitreal Implant in Retinal Vein Occlusion https://ClinicalTrials.gov/show/NCT03559491 Completed Università degli Studi dell’Insubria 2017-10-01
NCT00906659 Visual Function, Center Point Thickness and Macular Volume After Photocoagulation https://ClinicalTrials.gov/show/NCT00906659 Completed Hospital Juarez de Mexico 2007-12-31
NCT00886392 Diabetic Macular Edema Severity at Diagnosis https://ClinicalTrials.gov/show/NCT00886392 Completed Hospital Juarez de Mexico 2007-12-31
NCT01945892 Dexamethasone-Implant for the Treatment of Macula Edema Due to Irvine Gass Syndrome https://ClinicalTrials.gov/show/NCT01945892 Completed Ludwig-Maximilians - University of Munich 2013-06-30
NCT02850263 A Study to Assess the Effectiveness of Aflibercept in Routine Clinical Practice in Patients With Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT02850263 Active, not recruiting Bayer 2019-05-30
NCT03161912 A Study to Evaluate the Effectiveness of Intravitreal Aflibercept in Patients With Diabetic Macular Edema and/or Macular Edema Secondary to Retinal Vein Occlusion, Which Either Have or Have Not Been Pretreated for Their Disease https://ClinicalTrials.gov/show/NCT03161912 Recruiting Bayer 2021-08-31
NCT00791726 Microperimetry in Macular Edema https://ClinicalTrials.gov/show/NCT00791726 Completed St. Franziskus Hospital NA
NCT00763802 Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2 https://ClinicalTrials.gov/show/NCT00763802 Completed Association for Innovation and Biomedical Research on Light and Image 2010-09-30
NCT00759044 Validation of a New Methodology for Mapping the Human Blood-Retinal Barrier Function https://ClinicalTrials.gov/show/NCT00759044 Completed Association for Innovation and Biomedical Research on Light and Image 2010-10-31
NCT00709319 Evaluation of Vitrectomy for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00709319 Completed Jaeb Center for Health Research 2008-08-31
NCT00564291 Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT) https://ClinicalTrials.gov/show/NCT00564291 Recruiting University Hospital Inselspital, Berne 2021-12-31
NCT00563940 Short-term Effects of Intravitreal Bevacizumab and Triamcinolone in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00563940 Completed University Hospital Inselspital, Berne 2010-02-28
NCT00464581 Lucentis for Treatment of Macular Edema https://ClinicalTrials.gov/show/NCT00464581 Completed Retina Institute of Hawaii 2009-12-31
NCT00442156 The Course of Response to Focal Photocoagulation for DME https://ClinicalTrials.gov/show/NCT00442156 Completed Jaeb Center for Health Research 2008-06-30
NCT00797524 Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography https://ClinicalTrials.gov/show/NCT00797524 Completed Association for Innovation and Biomedical Research on Light and Image 2010-10-31
NCT00001738 Vascular Endothelial Growth Factor (VEGF) in Uveitis https://ClinicalTrials.gov/show/NCT00001738 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT01998412 Iluvien Registry Safety Study https://ClinicalTrials.gov/show/NCT01998412 Active, not recruiting Alimera Sciences 2020-01-31
NCT01824862 Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01824862 Completed Hospital Juarez de Mexico 2013-06-30
NCT04128150 High Resolution Retina Imaging https://ClinicalTrials.gov/show/NCT04128150 Recruiting Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts 2023-01-30
NCT03762226 Influence of Systemic Parameters in Diabetic Macular Edema - LIPSIA Study https://ClinicalTrials.gov/show/NCT03762226 Recruiting University of Leipzig 2021-06-30